TMCnet News

Research and Markets: Global Ocular Hypertension Pipeline Review H2 2015 - 17 Companies & 27 Drug Profiles
[November 26, 2015]

Research and Markets: Global Ocular Hypertension Pipeline Review H2 2015 - 17 Companies & 27 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/h4zm8f/ocular) has announced the addition of the "Ocular Hypertension - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Ocular Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ocular Hypertension and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.



Companies Involved in Therapeutics Development

  • Aerie Pharmaceuticals, Inc.
  • Allergan Plc
  • Amakem NV
  • Asahi Kasei Pharma Corp.
  • Bausch & Lomb Incorporated
  • Can-Fite BioPharma Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Inotek Pharmaceuticals Corporation
  • Merck & Co., Inc.
  • NicOx S.A.
  • Ocular Therapeutix, Inc.
  • Ono Pharmaceutical Co., Ltd.
  • Otsuka Holdings Co., Ltd.
  • Sanofi
  • Santen Pharmaceutical Co., Ltd.
  • Senju Pharmaceutical Co., Ltd.
  • Sylentis S.A.

Drug Profiles


  • (bimatoprost + brimonidine tartrate)
  • (carteolol hydrochloride + latanoprost)
  • (dorzolamide hydrochloride + latanoprost)
  • (latanoprost + trabodenoson)
  • (tafluprost + timolol maleate)
  • AMA-0076
  • AR-13324
  • ATS-8535
  • bamosiran
  • bimatoprost SR
  • DE-117
  • Gene Therapy for Steroid Induced Glaucoma and Ocular Hypertension
  • latanoprost
  • latanoprost SR
  • latanoprostene bunod
  • lomerizine
  • NCX-470
  • NCX-667
  • ONO-9054
  • OPA-6566
  • piclidenoson
  • RO-5093151
  • SAR-366234
  • SNJ-1656
  • tafluprost
  • trabodenoson
  • travoprost SR

For more information visit http://www.researchandmarkets.com/research/h4zm8f/ocular



[ Back To TMCnet.com's Homepage ]